{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:13:09Z","timestamp":1754194389268},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T00:00:00Z","timestamp":1397260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00296-014-3014-2","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T16:46:42Z","timestamp":1397234802000},"page":"1459-1463","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Longitudinal practice patterns of prophylaxis of glucocorticoid-induced osteoporosis in patients with polymyalgia rheumatica"],"prefix":"10.1007","volume":"34","author":[{"given":"Antonio","family":"Naranjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Garc\u00eda-Magall\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Jim\u00e9nez-Palop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"Ojeda-Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,12]]},"reference":[{"key":"3014_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-6009(91)90139-Q","volume":"8","author":"V LoCascio","year":"1990","unstructured":"LoCascio V, Bonucci E, Imbimbo B et al (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8:39\u201351","journal-title":"Bone Miner"},{"key":"3014_CR2","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","volume":"48","author":"TP Staa Van","year":"2003","unstructured":"Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arth Rheum 48:3224\u20133229","journal-title":"Arth Rheum"},{"key":"3014_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.reuma.2011.05.013","volume":"7","author":"L P\u00e9rez Edo","year":"2011","unstructured":"P\u00e9rez Edo L, Alonso Ruiz A, Roig Vilaseca D, Garc\u00eda Vadillo A, Gua\u00f1abens Gay N et al (2011) Actualizaci\u00f3n 2011 del consenso Sociedad Espa\u00f1ola de Reumatolog\u00eda de osteoporosis. Reumatol Clin. 7:357\u2013379","journal-title":"Reumatol Clin."},{"key":"3014_CR4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","volume":"19","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton LJ III et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893\u2013899","journal-title":"J Bone Miner Res"},{"key":"3014_CR5","doi-asserted-by":"crossref","unstructured":"Aguado Ac\u00edn MP (2007). Osteoporosis inducida por glucocorticoides: \u00bfqu\u00e9 hay de nuevo? Reumatol Clin 3(Suppl 1):3\u20138","DOI":"10.1016\/S1699-258X(07)73624-0"},{"key":"3014_CR6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.61.1.32","volume":"61","author":"B Gudbjornsson","year":"2002","unstructured":"Gudbjornsson B, Juliusson UI, Gudjonsson FV (2002) Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis 61:32\u201336","journal-title":"Ann Rheum Dis"},{"key":"3014_CR7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"Dasgupta B, Borg FA, Hassan N, Barraclough K, Bourke B, Fulcher J et al (2010) BSR and BHPR standards, guidelines and audit working group. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford) 49:186\u2013190","journal-title":"Rheumatology (Oxford)"},{"key":"3014_CR8","doi-asserted-by":"crossref","unstructured":"American College of Rheumatology Task Force on Osteoporosis Guidelines (1996) Recommendations for the prevention and treatment of glucocorticoid induced osteoporosis. Arthritis Rheum 39:1791\u20131801","DOI":"10.1002\/art.1780391104"},{"key":"3014_CR9","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","volume":"62","author":"JM Grossman","year":"2010","unstructured":"Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W et al (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 62:1515\u20131526","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3014_CR10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"HA Bird","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434\u2013439","journal-title":"Ann Rheum Dis"},{"key":"3014_CR11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","volume":"64","author":"B Dasgupsta","year":"2012","unstructured":"Dasgupsta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, Bachta A et al (2012) 2012 provisional classification criteria for Polymyalgia Rheumatica. Arthritis Rheum 64:943\u2013954","journal-title":"Arthritis Rheum"},{"key":"3014_CR12","unstructured":"FRAX. WHO fracture risk assessment tool. http:\/\/www.shef.ac.uk\/FRAX\/"},{"key":"3014_CR13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"KG Saag","year":"1998","unstructured":"Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S et al (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292\u2013299","journal-title":"N Engl J Med"},{"key":"3014_CR14","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","volume":"42","author":"S Cohen","year":"1999","unstructured":"Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M et al (1999) Risedronate therapy prevents corticosteroidinduced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 42:2309\u20132318","journal-title":"Arthritis Rheum"},{"key":"3014_CR15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","volume":"67","author":"S Wallach","year":"2000","unstructured":"Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF et al (2000) Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 67:277\u2013285","journal-title":"Calcif Tissue Int"},{"key":"3014_CR16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","volume":"15","author":"DM Reid","year":"2000","unstructured":"Reid DM, Hughes RA, Laan RF, Sacco-Gibson NA, Wenderoth DH, Adami S et al (2000) Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid- Induced Osteoporosis Treatment Study. J Bone Miner Res 15:1006\u20131013","journal-title":"J Bone Miner Res"},{"key":"3014_CR17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","volume":"373","author":"DM Reid","year":"2009","unstructured":"Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY et al (2009) Zoledronic acid and risedronate in the prevention and treatment of glucocorticoidinduced osteoporosis (HORIZON): a multicentre, double-blind, doubledummy, randomised controlled trial. Lancet 373:1253\u20131263","journal-title":"Lancet"},{"key":"3014_CR18","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","volume":"357","author":"KG Saag","year":"2007","unstructured":"Saag KG, Shane E, Boonen S, Marin F, Donley DW, Taylor KA et al (2007) Teriparatid or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357:2028\u20132039","journal-title":"N Engl J Med"},{"key":"3014_CR19","doi-asserted-by":"crossref","unstructured":"American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheu 44:1496\u20131503","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5"},{"key":"3014_CR20","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/art.21194","volume":"52","author":"JR Curtis","year":"2005","unstructured":"Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52:2485\u20132494","journal-title":"Arthritis Rheum"},{"key":"3014_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/RHU.0b013e31816b1931","volume":"14","author":"CV Caballero-Uribe","year":"2008","unstructured":"Caballero-Uribe CV, Acosta-Velez JG, Hernandez-Ruiz EA, Andrade Rodado FM, Pe\u00f1uela-Epalza M (2008) Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city. J Clin Rheumato 14:153\u2013155","journal-title":"J Clin Rheumato"},{"key":"3014_CR22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00198-010-1201-x","volume":"22","author":"L Caplan","year":"2011","unstructured":"Caplan L, Hines AE, Williams E, Prochazka AV, Saag KG, Cunningham F et al (2011) An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis. Osteoporos Int 22:305\u2013315","journal-title":"Osteoporos Int"},{"key":"3014_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/RHU.0b013e3181a5679d","volume":"15","author":"KA Coulson","year":"2009","unstructured":"Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH (2009) Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol 15:155\u2013160","journal-title":"J Clin Rheumatol"},{"key":"3014_CR24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/qjmed\/hcm126","volume":"101","author":"E Wall","year":"2008","unstructured":"Wall E, Walker-Bone K (2008) Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology. QJM 101:317\u2013323","journal-title":"QJM"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3014-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3014-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3014-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:53Z","timestamp":1559028113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3014-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,12]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3014"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3014-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,12]]}}}